Skip to main content
Clinical Trials/ACTRN12622000517774
ACTRN12622000517774
Not yet recruiting
未知

Evaluation of the effects of supplementation with Pycnogenol (French Pinus pinaster bark extract) on exercise performance in a population of cyclists: A double blind crossover trial.

a Trobe University0 sites20 target enrollmentStarted: March 31, 2022Last updated:

Overview

Phase
未知
Status
Not yet recruiting
Sponsor
a Trobe University
Enrollment
20

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 45 Years (—)
Sex
All

Inclusion Criteria

  • 1\. Adults between the ages of 18\-45
  • 2\. Actively participate in cycling (minimum 3 sessions per week)
  • 3\. competitive C grade rider or higher, completing approximately 200 km or more per week

Exclusion Criteria

  • 1\) Are pregnant and/or breastfeeding.
  • 2\) Present with a history of treatment for metabolic disease (e.g., diabetes or cardiovascular disease).
  • 3\) Are currently using any prescription medication which could impact on inflammatory pathways (e.g., Warfarin, aspirin, ibuprofen \[nurofen]).
  • 4\) Have any medical contraindications to exercise.
  • 5\) Are currently injured.

Investigators

Sponsor
a Trobe University

Similar Trials